These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
374 related articles for article (PubMed ID: 31663617)
41. EBV-miR-BART10-3p and EBV-miR-BART22 promote metastasis of EBV-associated gastric carcinoma by activating the canonical Wnt signaling pathway. Dong M; Gong LP; Chen JN; Zhang XF; Zhang YW; Hui DY; Zhao XX; Wu XY; Shao CK Cell Oncol (Dordr); 2020 Oct; 43(5):901-913. PubMed ID: 32533512 [TBL] [Abstract][Full Text] [Related]
42. Epstein-Barr virus positivity, not mismatch repair-deficiency, is a favorable risk factor for lymph node metastasis in submucosa-invasive early gastric cancer. Park JH; Kim EK; Kim YH; Kim JH; Bae YS; Lee YC; Cheong JH; Noh SH; Kim H Gastric Cancer; 2016 Oct; 19(4):1041-1051. PubMed ID: 26573601 [TBL] [Abstract][Full Text] [Related]
43. Glypican-4 gene polymorphism (rs1048369) and susceptibility to Epstein-Barr virus-associated and -negative gastric carcinoma. Zhao D; Liu S; Sun L; Zhao Z; Liu S; Kuang X; Shu J; Luo B Virus Res; 2016 Jul; 220():52-6. PubMed ID: 27071854 [TBL] [Abstract][Full Text] [Related]
44. Prognostic factors in Epstein-Barr virus-associated stage I-III gastric carcinoma: implications for a unique type of carcinogenesis. Huang SC; Ng KF; Chen KH; Hsu JT; Liu KH; Yeh TS; Chen TC Oncol Rep; 2014 Aug; 32(2):530-8. PubMed ID: 24899228 [TBL] [Abstract][Full Text] [Related]
46. Epstein-Barr Virus-associated Gastric Cancer and Potential Mechanisms of Oncogenesis. Morales-Sanchez A; Fuentes-Panana EM Curr Cancer Drug Targets; 2017; 17(6):534-554. PubMed ID: 27677953 [TBL] [Abstract][Full Text] [Related]
47. High prevalence of Epstein-Barr virus in gastric remnant carcinoma after Billroth-II reconstruction. Nishikawa J; Yanai H; Hirano A; Okamoto T; Nakamura H; Matsusaki K; Kawano T; Miura O; Okita K Scand J Gastroenterol; 2002 Jul; 37(7):825-9. PubMed ID: 12190097 [TBL] [Abstract][Full Text] [Related]
48. Epstein-Barr virus positivity among surgically resected intramucosal gastric cancer. Murai K; Kakushima N; Sugino T; Yoshida M; Kawata N; Tanaka M; Takizawa K; Muramatu K; Kusafuka K; Bando E; Ono H Dig Endosc; 2018 Sep; 30(5):667-671. PubMed ID: 29729036 [TBL] [Abstract][Full Text] [Related]
49. CD47 expression in Epstein-Barr virus-associated gastric carcinoma: coexistence with tumor immunity lowering the ratio of CD8 Abe H; Saito R; Ichimura T; Iwasaki A; Yamazawa S; Shinozaki-Ushiku A; Morikawa T; Ushiku T; Yamashita H; Seto Y; Fukayama M Virchows Arch; 2018 Apr; 472(4):643-651. PubMed ID: 29536167 [TBL] [Abstract][Full Text] [Related]
50. Gastritis-Infection-Cancer Sequence of Epstein-Barr Virus-Associated Gastric Cancer. Fukayama M; Kunita A; Kaneda A Adv Exp Med Biol; 2018; 1045():437-457. PubMed ID: 29896679 [TBL] [Abstract][Full Text] [Related]
51. [Clinicopathological and molecular characteristics of Epstein-Barr virus associated gastric cancer: a single center large sample case investigation]. Yang Y; Liu YQ; Wang XH; Ji K; Li ZW; Bai J; Yang AR; Hu Y; Han HB; Li ZY; Bu ZD; Wu XJ; Zhang LH; Ji JF Beijing Da Xue Xue Bao Yi Xue Ban; 2019 Jun; 51(3):451-458. PubMed ID: 31209416 [TBL] [Abstract][Full Text] [Related]
52. Prospective observation: Clinical utility of plasma Epstein-Barr virus DNA load in EBV-associated gastric carcinoma patients. Qiu MZ; He CY; Lu SX; Guan WL; Wang F; Wang XJ; Jin Y; Wang FH; Li YH; Shao JY; Zhou ZW; Yun JP; Xu RH Int J Cancer; 2020 Jan; 146(1):272-280. PubMed ID: 31162842 [TBL] [Abstract][Full Text] [Related]
53. [Genotyping of Epstein-Barr virus in Epstein-Barr virus associated gastric carcinoma]. Yang TT; Wang Y; Liu X; Li X; Pang ZC; Luo B Bing Du Xue Bao; 2009 Jan; 25(1):29-34. PubMed ID: 19437883 [TBL] [Abstract][Full Text] [Related]
54. Clinicopathologic Characteristics of Epstein-Barr Virus-Associated Gastric Cancer Over the Past Decade in Japan. Yanagi A; Nishikawa J; Shimokuri K; Shuto T; Takagi T; Takagi F; Kobayashi Y; Yamamoto M; Miura O; Yanai H; Suehiro Y; Yamasaki T; Yoshiyama H; Sakaida I Microorganisms; 2019 Sep; 7(9):. PubMed ID: 31480554 [No Abstract] [Full Text] [Related]
55. Epstein-Barr virus is absent in gastric superficial neoplastic lesions. Ribeiro J; Malta M; Galaghar A; Afonso LP; Libânio D; Medeiros R; Dinis-Ribeiro M; Pimentel-Nunes P; Sousa H Virchows Arch; 2019 Dec; 475(6):757-762. PubMed ID: 31673776 [TBL] [Abstract][Full Text] [Related]
56. Characteristics of Epstein-Barr virus-associated gastric cancer: a study of 235 cases at a comprehensive cancer center in U.S.A. Truong CD; Feng W; Li W; Khoury T; Li Q; Alrawi S; Yu Y; Xie K; Yao J; Tan D J Exp Clin Cancer Res; 2009 Feb; 28(1):14. PubMed ID: 19192297 [TBL] [Abstract][Full Text] [Related]
57. Frequency of Epstein--Barr virus infection as detected by messenger RNA for EBNA 1 in histologically proven gastric adenocarcinoma in patients presenting to a tertiary care center in South India. Rymbai ML; Ramalingam VV; Samarasan I; Chandran BS; Mathew G; Jerobin J; Abraham AM; Sachithanandham J; Kannangai R Indian J Med Microbiol; 2015; 33(3):369-73. PubMed ID: 26068337 [TBL] [Abstract][Full Text] [Related]
59. Epstein-Barr virus infection and its gene expression in gastric lymphoma of mucosa-associated lymphoid tissue. Xu WS; Chan AC; Lee JM; Liang RH; Ho FC; Srivastava G J Med Virol; 1998 Dec; 56(4):342-50. PubMed ID: 9829640 [TBL] [Abstract][Full Text] [Related]
60. Epstein-Barr virus in gastric carcinoma in Suzhou, China and Osaka, Japan: association with clinico-pathologic factors and HLA-subtype. Qiu K; Tomita Y; Hashimoto M; Ohsawa M; Kawano K; Wu DM; Aozasa K Int J Cancer; 1997 Apr; 71(2):155-8. PubMed ID: 9139835 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]